Patients, Doctors Await FDA Decision on Experimental Alzheimer's Drug | Health

THURSDAY, Jan. 5, 2023 (HealthDay News) -- Lecanemab: It's an experimental medication that's been shown in trials to slow cognitive decline in people with Alzheimer’s disease.

Related Keywords

Japan ,Northwestern University ,Illinois ,United States ,Ohio ,Chicago ,Japanese ,Americans ,Rudolph Castellani ,Marwan Sabbagh ,Babak Tousi ,Cleveland Clinic Center ,Drug Administration ,Northwestern University Medical Center ,Clinical Trials Program ,Brain Health ,Healthday News ,Cleveland Clinic ,New England Journal ,Science Insider ,Northwestern Medicine ,Consumer News ,